It has been shown in an in vivo study that TZD reduce serum DPP-4 activity as a result of reduced DPP-4 secretion and that DDP-4 is expressed in differentiated thyroid cancer cells but not in normal human thyrocytes [42]. The gene discussed is DPP4; the disease is thyroid cancer.